Your session is about to expire
← Back to Search
Low Level Laser Therapy
LH80 PRO for Male Pattern Baldness
Phase 2
Waitlist Available
Research Sponsored by Theradome, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights
Study Summary
This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.
Eligible Conditions
- Male Pattern Baldness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 26 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hair growth
Quantitative Hair Growth
Secondary outcome measures
Subject Self Assessment
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: LH80 PROActive Control1 Intervention
Low level laser therapy
Group II: Sham devicePlacebo Group1 Intervention
No low level laser therapy
Find a Location
Who is running the clinical trial?
Theradome, Inc.Lead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger